Journal of Dermatological Treatment

Article	Citations
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial	72
Topical delgocitinib for the treatment of chronic hand eczema	68
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits	62
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	50
Lessons from a decentralized trial in atopic dermatitis: promises and perils	45
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	39
Skin type classifications: does the perfect assessment exist?	36
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	34
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis	31
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	30
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	27
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	25
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	25
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	24
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	24
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	23
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	23
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study	22
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study	21
Driving taxis	21
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib	21
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	20
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study –	20
Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review	19
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	19

Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study	18
Finally, successful interventions to ameliorate cutaneous infestations	18
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years	18
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	18
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study	18
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	18
The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy	18
Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report	18
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)	17
A pediatric case of dupilumab-induced pustular psoriasis	17
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	16
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib	16
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	16
Exploring the potential of nanocarriers in antipsoriatic therapeutics	16
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study	16
Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis	15
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa	15
Correction	15
Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study	15
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis	15
Psychosocial interventions for psoriasis: a Bayesian network meta-analysis	15
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	15
A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency	14
Topical treatment for postinflammatory hyperpigmentation: a systematic review	14
The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season	14
Efficacy of skin flap transfer combined with negative pressure wound therapy in the management of complex pressure ulcers	14
Uses of eye drops in dermatology, literature review	13
Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer	13
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report	13
From clinical trial to real world evidence: a learning healthcare environment	13
Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey	13
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012–2018	13
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study	13
Correction	13
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study	12
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	12
Managing dry skin in patients with comorbidities or with advanced age: unmet needs and roles for products containing potential emollient-plus ingredients	12
A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations	12
Utilizing artificial intelligence technology with emotional intelligence in clinical office visits	12
Successful treatment of SAPHO syndrome with oral abrocitinib: a case report	12
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network	12
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD	12
Pre-operative ultrasound localization of misdiagnosed foreign object as verruca vulgaris: a case report	12
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	11
The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis	11
Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab	11
Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?	11
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	11
Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?	11
Polynucleotide-based treatments for various facial scars including combat injuries	11

Vitiligo outpatient management in the United States: findings from the 2012–2019 National Ambulatory Medical care Survey (NAMCS)	11
A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report	11
Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis	11
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis	10
Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis	10
Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders	10
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan	10
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	10
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin	10
Phototherapy trends in dermatology 2015–2018	10
Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis	10
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience	9
Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report	9
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special	9
Doxycycline monotherapy for pyoderma vegetans: a case report	9
New insights into delusional infestation	9
Treatment of eosinophilic annular erythema with upadacitinib	9
Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis	9
Characterization and therapeutic strategies for refractory vulvar lichen sclerosus: an 8-year single-center retrospective study and current evidence synthesis	9
Complementary and alternative treatment methods practiced by parents in pediatric cases diagnosed with atopic dermatitis	9
Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin	9
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study	9
Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab	9
Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review	9
Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in Japan	9
Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report	8
Successful treatment of cutaneous polyarteritis nodosa with baricitinib	8
A case of generalized eosinophilic pustular folliculitis: treatment with JAK inhibitor	8
Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy	8
Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment	8
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?	8
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial	8
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis	8
The efficacy of combined phototherapy with topical therapy in vitiligo: a network meta-analysis	8
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years	8
Delusional infestation: a case for preserving pimozide as an option	8
Clinical observations on super relaxation suture in the resection of benign skin tumor in children	8
Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review	8
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional,	8
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study	8
Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo	8
Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients	8
A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab	8
Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases	8
Another transition	8
Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases	7
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international pat	7
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis	7
Itraconazole versus propranolol: therapeutic and pharmacologic effect on serum angiopoietin-2 in patients with infantile hemangioma	7
Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis	7
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	7
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	7
Silicone-induced granulomas successfully treated with adalimumab	7
Dermatology in a changing world	7
Effects and safety of fire needle adjuvant chemical peels therapy in acne vulgaris: a systematic review and meta-analysis	7
Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report	7
Letter to the editor submitted in response to “Minoxidil: a comprehensive review”	7
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries	7
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study	7
Experiences and coping behaviors of patients with psoriasis: a qualitative study	7
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up st	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient	6
Preliminary analysis of the efficacy of Mohs micrographic surgery combined with photodynamic therapy in a case of noninvasive extramammary Paget’s disease	6
The impact of hormones in autoimmune cutaneous diseases	6
Anatomical-based diagnosis and filler injection techniques: marionette line (static labiomandibular fold)	6
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective	6
Comparison of the onset, depth, and duration of cutaneous anesthesia between topical 10% lidocaine and EMLA creams: a randomized, intraindividual, comparative trial	6
Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review	6
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis	6
Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa	6
Efficacy and safety of a novel 785 nm picosecond neodymium-doped yttrium aluminum garnet laser for the treatment of facial benign pigmented lesions in Asian skin: a pilot study	6
Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life	6
UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities	6
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting	6
Baseline hair loss severity as a potential confounder in studies on minoxidil and low-level laser therapy	6
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research	6
Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials	6
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	6
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis – a pilot study	6

CHILD syndrome combined linear porokeratosis in a patient with a good response to the topical lovastatin/cholesterol ointment	6
Two cases of lupus miliaris disseminatus faciei successfully treated with oral tofacitinib	6
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment	6
Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective	6
The effects of topical antimicrobial-corticosteroid combination therapy in comparison to topical steroids alone on the skin microbiome of patients with atopic dermatitis	6
Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis	6
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients	5
Mandated step therapy for dupilumab delays the inevitable	5
Development of a new classification and scoring system for scalp conditions: Scalp Photographic Index (SPI)	5
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma	5
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	5
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps	5
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	5
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials	5
Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study	5
Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab	5
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	5
Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review	5
Behcet’s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review	5
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials	5
Successful guselkumab treatment for a psoriasis patient experiencing an adrenal crisis: a case report	5
Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad	5
Health disparities in psoriasis: geographic barriers to access in the United States	5
Pattern hair loss distribution: a novel presentation for alopecia areata	5
Observational study on postoperative JAK inhibitor and corticosteroid therapy following non-cultured epidermal cell suspension transplantation in stable vitiligo patients	5
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa	5
A case of topical imiquimod induced fatigue	5
Are cyclosporine eye drops a suitable treatment in ocular rosacea?	5
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	5
A network meta-analysis study of monotherapies for hidradenitis suppurativa: analyses of the current evidence base	5
Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study	5
Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023)	5
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals	5
A new hope in the treatment of onychogryphosis due to acquired malalignment of great toenails: intramatrix dexpanthenol injection	5
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks	5
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors	5
Introducing a simplified titration scheme for dimethylfumarate (DMF) in patients with moderate-to-severe psoriasis: a case series	5
Low-dose oral minoxidil in a case of short anagen syndrome	5
Killing all the birds with one drug – is oral roflumilast a novel treatment option for psoriasis?	5
Association of pruritus and chronic cough: an all of us database study	5
The relative weak way and the absolute strong way to communicate risk information	5
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry	5
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis	5
Social media voices on the treatment of skin psoriasis with biologics	5
Hedgehog pathway inhibitors (HHI) combined with radiotherapy and immunotherapy for advanced basal cell carcinoma: a case report	5
Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study	4
Switching biologic agent in patients with psoriasis: a systematic review and meta-analysis	4
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	4
Pemphigus foliaceus treated with minocycline monotherapy or low-dose prednisolone combination therapy	4
Ocular side effects of systemic isotretinoin – a systematic review and summary of case reports	4
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials	4
Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study	4
Risk of fetal malformation, spontaneous abortion, and adverse pregnancy outcomes after gestational terbinafine exposure: a systematic review	4
Modalities of treatment for Nevus depigmentosus: review of the literature	4
A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children	4
Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated	4
Time to codify a challenge in communication	4
Topical treatment adherence and writing clarity: insights from a precision dispenser study	4
Unlocking potential: clinical benefits of enlarging the nail bed explored through continuous W-shaped incisions	4
A systematic review investigating the proportion of clinical images shared in prospective randomized controlled trials involving patients with atopic dermatitis and systemic pharmacotherapy	4
Self-perceived disease control in childhood eczema	4
Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States	4
The landscape of vitiligo in Latin America: a call to action	4
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience	4
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting	4
Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy – a mixed-method pilot study	4
Efficacy analysis of blunt separation combined with uncrosslinked sodium hyaluronate compound solution injection for sunken upper eyelid treatment in Asians	4
TNF-α inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series	4
The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa	4
Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment	4
Patient preferences for topical psoriasis treatments: a discrete choice experiment	4
Hemodynamic changes during conventional and daylight photodynamic therapy of actinic keratoses – a randomized controlled trial	4
Burden of chronic spontaneous urticaria relative to atopic dermatitis and psoriasis in the United States	4
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group	4
Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience	4
Monitoring adherence to vulvar lichen sclerosus treatment – a prospective study	4
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa	4
Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics	4
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study	4
Efficacy and safety of the combination therapy of CO 2 laser and thalidomide in cutaneous classic Kaposi’s sarcoma	4
Off-label dermatologic uses of IL-23 inhibitors	4
The evolving landscape for vitiligo management	4
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study	4
Efficacy prediction model of hematoporphyrin monomethyl ether photodynamic therapy for facial port-wine stains	4
A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis	4
Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review	3
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis	3
Seven years-experience of adalimumab therapy for Hidradenitis Suppurativa in a real-life dermatologic setting	3
Comparative efficacy and safety of targeted narrowband ultraviolet B, 308-nm excimer laser, and 308-nm excimer lamp in vitiligo: a retrospective study	3
When is it appropriate to make clinical recommendations?	3
Family planning and pregnancy among patients with psoriasis: incorporating the patients’ voice in healthcare practice and information provision	3
Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States	3
Onychopapilloma: a single medical center experience in Southern Taiwan	3
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment	3
Racial differences in access to psoriasis biologics	3